These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 36123287)
1. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma. Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287 [TBL] [Abstract][Full Text] [Related]
2. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma. Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314 [TBL] [Abstract][Full Text] [Related]
3. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway. Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867 [TBL] [Abstract][Full Text] [Related]
4. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway. Sun MY; Wang L; Shen ZY Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056 [TBL] [Abstract][Full Text] [Related]
5. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway. Chen M; Zhang J J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling. Liu M; Gao X; Liu CL Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871 [TBL] [Abstract][Full Text] [Related]
7. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway. Qu Y; He Y; Ruan H; Qin L; Han Z Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972 [TBL] [Abstract][Full Text] [Related]
9. Circ_0058063 Contributed to Oral Squamous Cell Carcinoma Development by Sponging miR-145 and Regulating PI3K/AKT Pathway. Zhou J; Jin S Mol Biotechnol; 2023 Dec; 65(12):2049-2060. PubMed ID: 36928742 [TBL] [Abstract][Full Text] [Related]
10. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral. Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741 [TBL] [Abstract][Full Text] [Related]
11. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma. Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505 [TBL] [Abstract][Full Text] [Related]
12. ZNF677 inhibits oral squamous cell carcinoma growth and tumor stemness by regulating FOXO3a. Zhang Z; Zhang Y; Hu X; Chen Y; Zhuang L; Zhang S Hum Cell; 2023 Jul; 36(4):1464-1476. PubMed ID: 37129799 [TBL] [Abstract][Full Text] [Related]
13. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma. Zhang M; Lin H; Ge X; Xu Y J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer. Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306 [TBL] [Abstract][Full Text] [Related]
15. Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP-associated OSCC. Liu Y; Cao P; Xiao L; Tang N; Fei W; Li X J Cell Mol Med; 2024 Jul; 28(14):e18556. PubMed ID: 39039706 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression. Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182 [TBL] [Abstract][Full Text] [Related]
17. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression. Zhang G; Wang H; Liu G; Huang J Pathol Res Pract; 2024 Jan; 253():155021. PubMed ID: 38103366 [TBL] [Abstract][Full Text] [Related]
18. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway. Fan QC; Tian H; Wang Y; Liu XB Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080 [TBL] [Abstract][Full Text] [Related]
19. P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma. Chi Z; Wang Q; Wang X; Li D; Tong L; Shi Y; Yang F; Guo Q; Zheng J; Chen Z Sci Rep; 2024 Jul; 14(1):15023. PubMed ID: 38951593 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway. Wang Q; Zhang X; Song X; Zhang L Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]